Restamax Plc: MANAGERS' TRANSACTIONS Restamax Plc

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Restamax Plc: MANAGERS' TRANSACTIONS
Restamax Plc MANAGERS' TRANSACTIONS 28 DECEMBER 2016 at 22:00 Restamax Plc: MANAGERS' TRANSACTIONS  Person subject to the notification requirement
Name:JS-RESTA OYLegal Person
Position:Closely associated person
 
Person discharging managerial responsibilities in issuer
Name:SUOMINEN, JARNO
Position:Chief Financial Officer
 
   
Initial Notification 
Reference number:D662
   
Issuer
Name:RESTAMAX OYJ
LEI:743700DYZ6R1QNLWQA56
   
Transaction details
Transaction date:2016-12-23
Venue:NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction:Disposal
 
Instrument:Share
ISIN:FI4000064332
 
Volume:18280.00
Unit price:6.00 Euro
Volume:200.00
Unit price:6.03 Euro
Volume:247.00
Unit price:6.05 Euro
Volume:250.00
Unit price:6.01 Euro
Volume:120.00
Unit price:6.05 Euro
Volume:100.00
Unit price:6.09 Euro
Volume:803.00
Unit price:6.05 Euro
 
Aggregated transactions
Volume:20000.00
Volume weighted average price:6.0038 Euro

Additional information: Jarno Suominen, CFO, Restamax Plc, tel. +358 40 721 5655

Restamax Plc is a Finnish restaurant business and labour hire services group established in 1996. The company, which listed on NASDAQ OMX Helsinki in 2013 and became the first Finnish listed restaurant company, has continued to grow strongly throughout its history. The group companies include over 100 restaurants, nightclubs and entertainment centres all over Finland. Well-known restaurant concepts of the group include Stefan's Steakhouse, Viihdemaailma Ilona and Classic American Diner. In 2015, Restamax Plc's turnover was MEUR 113.7 and EBITDA MEUR 16.5. Depending on the season, some 1,000 persons work at the group. The workforce of Restamax subsidiary Smile Henkilöstöpalvelut Oy is about 3,000.

Restamax company website: www.restamax.fi, Restamax consumer website: www.ravintola.fi, Smile Henkilöstöpalvelut: www.smilepalvelut.fi

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Protecting Shareholder Rights: iRhythm Technologies Update

Updated Category News Views 104

Understanding Your Rights as a Shareholder For shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), it's imperative to be proactive regarding your rights. Engaging with legal experts can significantly empower your ability to affect change and seek justice for any personal or collective grievances stemming from corporate actions. Why Shareholder Action is Crucial...

Continue Reading
Discover the New Credit Risk IQ and its Industry Insights

Updated Category News Views 138

Introducing Credit Risk IQ Credit Benchmark, a leader in delivering essential credit risk data and analytics, has launched an exciting new platform called Credit Risk IQ. This online portal features an extensive library of over 5,000 free monthly reports that explore credit trends at both industry and sector levels. The insights found in these reports are invaluable for...

Continue Reading
9Rooftops Retained as Marketing Agency for South Carolina Tourism

Updated Category News Views 233

9Rooftops Reappointed for South Carolina Tourism Marketing 9Rooftops, known for its innovative marketing strategies, has been reappointed as the Marketing and Advertising Agency of Record for the South Carolina Department of Parks, Recreation & Tourism (SCPRT). This marks a continued partnership aimed at showcasing the beauty and attractions of South Carolina. A...

Continue Reading
Kyivstar Enhances Digital Services with AI Cloud Solutions

Updated Category News Views 203

Kyivstar Revolutionizes Cloud Services with AI Integration Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) has embarked on an ambitious journey to strengthen digital services within Ukraine. The company has officially announced the integration of groundbreaking artificial intelligence (AI) technologies into its cloud platform, Kyivstar Cloud. This advancement is pivotal for all...

Continue Reading
Akeso Advances Cancer Care with Ivonescimab Phase III Trial Launch

Updated Category News Views 171

Akeso Launches Phase III Trial for Ivonescimab in SCLC Akeso, Inc. (9926.HK) recently announced an exciting milestone in cancer treatment with the first patient being dosed in its Phase III clinical trial. This multicenter, randomized, and double-blind study, named AK112-311/HARMONi-9, evaluates the efficacy and safety of ivonescimab, a unique bispecific antibody that...

Continue Reading